Skip to content
  • Home
  • Journalists
    • Headlines
  • Community
    • Businesses
    • Jobs
    • Learning
    • Marketplace
  • Store
(@)

FDA Makes Alzheimer’s Drug Leqembi Widely Accessible

The F.D.A. gave full approval to the drug, but added a black-box warning about safety risks. Medicare said it would cover most of the high cost.

Pam Belluck
Author: Pam Belluck

Written by

Pam Belluck

in

Centers for Medicare and Medicaid Services, Decisions and Verdicts, Drugs (Pharmaceuticals), Eisai Co Ltd, Food and Drug Administration, Medicare, Memory, United States
←At Wimbledon, Sofia Kenin Rediscovers Her Fighting Form
Ron DeSantis Raises $20 Million For Campaign, Behind Trump→

More posts

  • Storms expected on both coasts threatens Thanksgiving travel

  • Mexico detains top cartel boss ‘El Chapo Isidro,’ setting off violence

  • Jeffries says Jordan contacted him after Speaker vote, but not Trump or Vance

  • Trump Defends Stephen Miller After Future House Speaker Hakeem Jeffries Calls Him ‘Racist’

About Us


Support Us

Trademark & Copyright 1998 – 2025 · MOSAEC

  • Facebook
  • Instagram
  • LinkedIn
  • YouTube